Asymptomatic intraplacental choriocarcinoma is a rare event with only a few case reports in the literature. The recognition of such a lesion on routine placental examination is important and prompts rapid clinical evaluation for identifying residual and/or metastatic disease followed by institution of chemotherapy. Failure to recognize such a lesion on gross inspection of the placenta can result in disseminated disease, which can be lethal. The following report describes the placental findings and clinical outcome in a recent case with a review of the relevant literature.
CASE REPORT
This 21-year-old gravida 4, para 3, Latin American woman had a cesarean section at 37 weeks' gestation due to fetal intolerance to labor induced for decreased variability in the fetal heart rate. The newborn healthy male infant weighed 6 pounds and 12 oz and had Apgar scores of 7 and 9 at 1 and 5 minutes, respectively. Past obstetrical history included a cesarean section in 1992 for a stillborn infant at 28 weeks, a preterm vaginal delivery at home at 32 weeks resulting in a healthy infant in 1994, and a term, uncomplicated vaginal delivery in October 1995. The patient had an uncomplicated postoperative recovery and was discharged from the hospital on the third postoperative day.
Placental examination revealed a 430-gm placental disc with a focal pale soft area measuring 2 cm in diameter and located in the mid-zone of the placenta, 3 cm from the nearest margin and 3 cm from the cord insertion site (Figure 1 ). It extended from the maternal surface 1.5 cm into the villous tissue. Microscopic examination ( Figure 2 ) revealed this area to be composed of pleomorphic cytotrophoblast and syncytiotrophoblast with extensive central necrosis. There was invasion of the malignant trophoblast into the villous stroma, without invasion of the vessels, and foci of infarction at the edges of the tumor. The margins were irregular with insinuation into the adjacent villous tissue. Multiple sections taken away from the grossly identified tumor were unremarkable.
Attempts to locate the patient were unfruitful. She presented 20 days later complaining of vaginal bleeding since the delivery, which had increased in the last few days. Examination revealed a tender, enlarged uterus about 12 cm in size. A pelvic ultrasound did not reveal any mass in the uterus. Beta human chorionic gonadotropin (hCG)at this time was 61,088 IU/l. Pulmonary metastases were detected by chest radiograph and computerized tomography. Four pulmonary nodules were noted with the largest measuring 3 ϫ 2.5 cm (Figure 3) . Treatment was begun with combination chemotherapy consisting of VP-16, actinomycin, and methotrexate followed by vincristine and cytoxan. There was a steady fall in the beta hCG levels from 61,088 IU/l (pretreatment), to Ͻ5 IU/l within 8 weeks of therapy, and finally, to an undetectable level. The infant is healthy and his serum beta hCG has been consistently undetectable.
DENOUEMENT AND DISCUSSION
The incidence of choriocarcinoma following a normal pregnancy is approximately 1:160,000. 1 The origin of this tumor in an otherwise http://www.stockton-press.co.uk
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normal placenta, without maternal metastasis at the time of diagnosis, hence "asymptomatic," has been rarely documented. The terms "intraplacental choriocarcinoma" 2 or "choriocarcinoma in situ" 3 have been used for such a presentation. Published reports of such cases are detailed in Table 1 . 4 -12 Recognition of such lesions during routine placental examinations can be difficult because they can be very small and can grossly resemble an infarct. In one of the cases reported by Santamaria et al., 3 microscopic foci of choriocarcinoma were noted even in areas that were grossly normal. It is therefore possible that cases of choriocarcinoma diagnosed following a normal pregnancy may have originated in the placenta. Choriocarcinoma in situ has also been reported as an incidental finding in curettings from a nonmolar first trimester pregnancy 13 and in association with a partial hydatidiform mole. 14 It is therefore also conceivable that some choriocarcinomas are new pregnancies, especially those following a molar or nonmolar pregnancy after a prolonged interval of time. 15, 16 Intraplacental choriocarcinoma can result in maternal and/or fetal metastasis. It is not clear what factors predict such a behavior. Invasion of fetal vessels by the tumor, although not described, may account for fetal metastases. This finding was not observed in our case. In the 13 prior reports of intraplacental choriocarcinoma presented in Table 1 , five mothers were subsequently detected to have metastases and two died of the disease. Prompt monitoring of serum beta hCG levels and institution of appropriate chemotherapy play a crucial role in management. Since these tumors, irrespective of size, have almost always been associated with markedly elevated hCG levels, routine serum hCG measurement at term may play a role in selecting cases for placental examination and provide an early diagnosis. Both cases reported by Santamaria et al. 3 had fetal-maternal hemorrhage, and these authors suggest that massive fetal-maternal hemorrhage should prompt a detailed placental examination to de- tect an intraplacental choriocarcinoma that may not be evident on gross inspection. In addition, increased awareness of such an entity among obstetricians and pathologists may lead to detection of more cases and shed light on the biology of this neoplasm. 
